136 related articles for article (PubMed ID: 27566024)
1. Sentinel node biopsy in patients with primary cutaneous melanoma of any thickness: A cost-effectiveness analysis.
Serra-Arbeloa P; Rabines-Juárez ÁO; Álvarez-Ruiz MS; Guillén-Grima F
Surg Oncol; 2016 Sep; 25(3):205-11. PubMed ID: 27566024
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of sentinel node biopsy in patients with intermediate thickness primary cutaneous melanoma.
Morton RL; Howard K; Thompson JF
Ann Surg Oncol; 2009 Apr; 16(4):929-40. PubMed ID: 18825458
[TBL] [Abstract][Full Text] [Related]
3. Utility of sentinel lymph node biopsy for solitary dermal melanomas.
Hu Y; Shah P; Stukenborg GJ; Slingluff CL
J Surg Oncol; 2015 Jun; 111(7):800-7. PubMed ID: 25712273
[TBL] [Abstract][Full Text] [Related]
4. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
[TBL] [Abstract][Full Text] [Related]
5. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
6. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value.
Vermeeren L; Van der Ent F; Sastrowijoto P; Hulsewé K
Eur J Dermatol; 2010; 20(1):30-4. PubMed ID: 19889594
[TBL] [Abstract][Full Text] [Related]
8. Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications.
Morton RL; Tran A; Vessey JY; Rowbotham N; Winstanley J; Shannon K; Spillane AJ; Stretch J; Thompson JF; Saw RP
Ann Surg Oncol; 2017 Aug; 24(8):2071-2079. PubMed ID: 28321690
[TBL] [Abstract][Full Text] [Related]
9. Modelling the cost-effectiveness of sentinel lymph node mapping and adjuvant interferon treatment for stage II melanoma.
Wilson LS; Reyes CM; Lu C; Lu M; Yen C
Melanoma Res; 2002 Dec; 12(6):607-17. PubMed ID: 12459651
[TBL] [Abstract][Full Text] [Related]
10. Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.
van der Ploeg AP; Haydu LE; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF; Scolyer RA; Thompson JF
Ann Surg; 2014 Jul; 260(1):149-57. PubMed ID: 24633018
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
Brar H; Hogen L; Covens A
Cancer; 2017 May; 123(10):1751-1759. PubMed ID: 28117888
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy is prognostic but not therapeutic for thick melanoma.
Kachare SD; Singla P; Vohra NA; Zervos EE; Wong JH; Fitzgerald TL
Surgery; 2015 Sep; 158(3):662-8. PubMed ID: 26096561
[TBL] [Abstract][Full Text] [Related]
13. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
14. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
15. Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.
Lee NC; Spillane AJ; Pang TC; Haydu LE; Uren RF
Ann Surg Oncol; 2012 Jan; 19(1):280-6. PubMed ID: 21833669
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy in thin and thick melanoma.
Mozzillo N; Pennacchioli E; Gandini S; Caracò C; Crispo A; Botti G; Lastoria S; Barberis M; Verrecchia F; Testori A
Ann Surg Oncol; 2013 Aug; 20(8):2780-6. PubMed ID: 23720068
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
18. The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma.
Kachare SD; Brinkley J; Wong JH; Vohra NA; Zervos EE; Fitzgerald TL
Ann Surg Oncol; 2014 Oct; 21(11):3377-85. PubMed ID: 25063010
[TBL] [Abstract][Full Text] [Related]
19. Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases.
Piazzalunga D; Ceresoli M; Allievi N; Ribero S; Quaglino P; Di Lorenzo S; Corradino B; Campana LG; Mocellin S; Rossi CR;
Eur J Surg Oncol; 2019 May; 45(5):820-824. PubMed ID: 30527782
[TBL] [Abstract][Full Text] [Related]
20. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]